Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | AP2M1 |
| Upstream (Parents) |
|---|
| (<<) CCT7 → AP2M1 |
| (<<) OAZ1 → AP2M1 |
| (<<) VAMP8 → AP2M1 |
| Downstream (Children) |
|---|
| AP2M1 → CCT7 (>>) |
| AP2M1 → CAPG (>>) |
| AP2M1 → HLA-C (>>) |
| AP2M1 → CAT (>>) |
| AP2M1 → C4B///C4A (>>) |
| AP2M1 → CRIP2 (>>) |
| AP2M1 → SDF4 (>>) |
| AP2M1 → CDK6 (>>) |
| AP2M1 → PEG3 (>>) |
| AP2M1 → TGM4 (>>) |
| AP2M1 → FLNA (>>) |
| AP2M1 → TGOLN2 (>>) |
| AP2M1 → PKM2 (>>) |
| AP2M1 → CDK2AP2 (>>) |
| AP2M1 → BAD (>>) |
| AP2M1 → ELOVL1 (>>) |
| AP2M1 → SLC17A7 (>>) |
| AP2M1 → MRPS34 (>>) |
| AP2M1 → VAMP8 (>>) |
